| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $3.35 | - | - |
| Q1'26 | $3.06 | $2.88 | -5.9% |
| Q4'25 | $1.59 | $-0.33 | -120.8% |
| Q3'25 | $3.37 | $3.49 | +3.5% |
| Q2'25 | $3.55 | $3.35 | -5.7% |
| Q1'25 | $3.19 | $2.65 | -16.8% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.1B | - | - |
| Q1'26 | - | $1.0B | - |
| Q4'25 | $976M | $951M | -2.5% |
| Q3'25 | - | $1.1B | - |
| Q2'25 | - | $1.1B | - |
| Q1'25 | - | $989M | - |
Market Data
ERIE is currently trading at $224.90, giving Erie Indemnity Company a market cap of 10.44B and a P/E ratio of 18.3. Today's range spans $224.90–$224.90, with shares opening at $224.90 and moving up $0.67 (0.3%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL) with a news sentiment reading of 45/100.
Over the past year ERIE has traded between $210.06 and $380.67 - the current price is +7.1% off the 52-week low and -40.9% from the high.
Factor models are actively underweighting ERIE: large-cap, Financial Services, 10.44B market cap, 27/100 (SELL), neutral sentiment (45/100). Price: $224.90 (near 52-week lows). (P/E: 18.3) Momentum and trend-following strategies reduce exposure when scores drop below the 27/100 threshold; quality factors recalibrate; low-vol strategies find better risk-adjusted alternatives elsewhere in the sector. Annual range: $210.06–$380.67. The systematic de-risking compounds the fundamental concern.
The current SELL phase for ERIE (27/100) at $224.90 (near 52-week lows) suggests that the market is discounting either a fundamental deterioration or a sector headwind that hasn't fully appeared in the earnings line yet. Sentiment at 45/100 (neutral) confirms that news flow is not providing a counternarrative. At 10.44B in Financial Services capitalization, ERIE has the liquidity for institutional exits to be orderly — but orderly doesn't mean shallow within the $210.06–$380.67 range.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines